Mediastinal and intra-abdominal lymphadenopathy lymphadenopathy
Conditions
Interventions
To evaluate the selection of the most effective and safest needle for lymph node biopsy (EUS-TA) using either a 19GFNA needle or an FNB needle, a prospective comparative study will be conducted using
19G needle EUS-TA
Sponsors
Okuno Mitsuru
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Cases with mediastinal or abdominal lymphadenopathy detected by CT or ultrasound imaging. 2. Cases with lymphadenopathy without a pathological diagnosis. 3. Patients aged 18 years or older. 4. Lymphadenopathy of 10mm or greater. 5. Patients not taking oral anticoagulants.
Exclusion criteria
Exclusion criteria: 1. Cases in which a pathological diagnosis of lymph node swelling has already been made 2. Cases in which endoscopic examination is difficult 3. Cases in which consent to participate in this study cannot be obtained 4. Other cases in which this study is considered medically inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of histopathological examination: Non-inferiority of 19G FNA needle to 19G FNB needle | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological cytological accuracy Sensitivity of immunohistochemical staining in malignant lymphoma Sensitivity of surface markers in malignant lymphoma Sensitivity of chromosome testing in malignant lymphoma Sensitivity of FISH in malignant lymphoma | — |
Contacts
Public ContactMitsuru Okuno
Matsunami General Hospital
Outcome results
None listed